Why BGPT?
logo

Check Claims Before You Publish

See how your reported results read as versioned evidence records β€” linked to experiments and limitations.Know what the science actually supports before you trust the answer.

Press Enter ↡ to review claims


     Quick Explanation



    Edward J. Oakeley is a highly productive, collaborative molecular biologist (h-index 44–45, ~14,700–15,800 citations across 93–145 works) whose strength lies in genomics/transcriptomics methods and epigenetics, contributing to landmark Nature papers on flagellin perception, DNA methylation, and RNA-seq quality control. His cited work is methodologically rigorous but largely middle-author and technically focused.


     Long Explanation



    Citation Metrics and Impact

    OpenAlex records 145 works, ~15,820 citations, and an h-index of 45 for Edward J. Oakeley (ORCID 0000-0001-6226-7470), while Semantic Scholar-style data reports an h-index of 44 with 14,666 citations over 93 papers β€” a discrepancy suggesting inconsistent author disambiguation, a known limitation of bibliometric databases. His citation trajectory peaked in 2003–2011 (e.g., 3,376 citations in 2004, 1,646 in 2011), then declined; a striking spike of 43 works in 2023 with only 11 citations suggests catalogued conference abstracts rather than primary research. His most-cited contributions are collaborative: flagellin perception in Arabidopsis (1,841 citations, Nature 2004), chromosome-wide DNA methylation mapping (1,783 citations, Nature Genetics 2005), and mouse methylome regulation (1,506 citations, Nature 2011) .

    Cited Primary Work Quality

    The two detailed papers show strong methodological breadth. The sFRP1 breast cancer study (Breast Cancer Research, 2009) reports in vitro (TOPFlash 2.7-fold reduction, 31% proliferation decrease) and in vivo xenograft effects (68% vs 20% tumor-free mice at day 39; 20-fold fewer lung metastases), with GEO data deposition (GSE13806) and explicit single-cell-line limitations . The 1998 collodion-film method paper is a practical techniques contribution with good reproducibility (8/10) but limited quantitative benchmarking .

    Critical Assessment

    Oakeley's profile reflects a core-facility/collaborative genomics expert (FMI, Novartis, Basel ecosystem) rather than a project lead: nearly all top papers position him as a middle author providing bioinformatics, transcriptomics, or methylation analysis. Blind spots include single-model studies (one breast cancer line; limited cell types in methods papers), declining primary-output post-2016, and heavy reliance on co-author prestige for citation metrics. Strengths: sustained methodological rigor, data deposition practices, and contributions to RNA-seq quality standards (SEQC, 1,098 citations) .



    Feedback:    

    Updated: October 07, 2026

     BGPT Author Review



    Scientific Quality

    80%

    High-impact contributions to epigenetics, plant immunity, and genomics standards via Nature/Nature Genetics/PNAS papers; h-index ~45 indicates sustained influence. However, he is almost never first/last author on landmark works, so his independent scientific leadership is harder to judge. Metrics inflated by collaborative prestige and by 43 low-citation 2023 catalogued entries.



    Communication Quality

    70%

    Papers include clear methods detail, data deposition (GEO), and practical protocols (collodion paper is unusually instructional). But communication is technique-oriented; conceptual narrative and mechanistic storytelling are carried by lead authors.



    Author Novelty

    70%

    Contributed to genuinely new platforms (flagellin perception, methylome mapping, RNA-seq QC, gene-signature potency prediction), but mostly as an implementer; the collodion method is a modest incremental technique.



    Scientific Rigor

    80%

    Strong practices: GEO deposition, GC-RMA normalization, explicit statistical thresholds, falsification-oriented design, disclosed limitations (single cell line, in vivo/in vitro context dependency). Weaknesses: single-model reliance and incomplete mechanistic dissection of in vivo gene changes.

     Hypothesis Graveyard



    Oakeley's 2023 spike (43 works, 11 citations) signals a late-career productivity surge; better explained by OpenAlex indexing of conference abstracts/proceedings rather than new primary research.

     Science Art


    Author Review: Edward J Oakeley Science Art

     Science Movie



    Make a narrated HD Science movie for this answer ($32 per minute)




     Discussion


    Stay current without chasing every paper.

    Know what changed, what holds up, and what remains uncertain. Every Friday. No ads.


    My BGPT